Search Results
47 items found for "Heart failure"
- GRK2 in cardiovascular disease and its potential as a therapeutic target
Despite major advances in the field of pharmacological CVD treatments, particularly in the field of heart failure (HF) research, case numbers and overall mortality remain high and have trended upwards over differential domains of GRK2 to modulate both beneficial and deleterious signaling pathways in the heart
- The complicated lives of GPCRs in cardiac fibroblasts
events driving the fibrotic response and the communications between fibroblasts and other cells in the heart
- Adrenal G Protein-Coupled Receptors and the Failing Heart: A Long-distance, Yet Intimate Affair
October 2022 "Systolic heart failure (HF) is a chronic clinical syndrome characterized by the reduction alterations that confer significant hormonal burden on the already compromised function of the failing heart receptor antagonists, which block the effects of angiotensin II (AngII) and aldosterone on the failing heart
- G protein-coupled receptor kinase type 2 and β-arrestin2: Key players in immune cell functions...
β-arrestin2 play multiple roles in the pathological mechanisms of a wide range of diseases including heart failure, cancer, and inflammatory diseases.
- 📰 GPCR Weekly News, January 29 to February 4, 2024
on their work entitled β-arrestins and their potential role in heart failure. Dr. inflammatory diseases β-adrenergic receptor signaling mediated by β-arrestins and its potential role in heart failure GPCRs in Neuroscience Role of lipids in the control of autophagy and primary cilium signaling
- Dr. GPCR University registration is now open! Secure your spot now!
Biased Signal Transduction Pathways Activation of a GPCR, ORL1 receptor: A novel therapy to prevent heart failure progression GPCR Binders, Drugs, and more Advances in GPCR-targeted drug development in dermatology
- 📰 GPCR Weekly News, June 24 to 30, 2024
as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone Tectonic bets on GPCR heart failure drug following reverse merger with Avrobio Lilly signs $140M upfront partnership with Radionetics
- 📰 GPCR Weekly News, April 24 to 30, 2023
GPCRs in Cardiology, Endocrinology, and Taste Targeting G Protein-Coupled Receptors for Heart Failure
- 📰 GPCR Weekly News, February 20 to 26, 2023
and Taste α1-Adrenergic Receptors: Insights into Potential Therapeutic Opportunities for COVID-19, Heart Failure, and Alzheimer's Disease.
- 📰 GPCR Weekly News, June 17 to 23, 2024
synergistic membrane-to-nucleus information transfer TMC6 functions as a GPCR-like receptor to sense noxious heat Monlunabant by Inversago Pharma for Metabolic Syndrome: Likelihood of Approval Tectonic bets on GPCR heart failure drug following reverse merger with Avrobio Addex Pharma unveils new mGlu7 receptor negative
- 📰 GPCR Weekly News, July 1 to 7, 2024
metabolic diseases: pharmacotherapeutic development updates Targeting G protein-coupled receptors for heart failure treatment RAMP and MRAP accessory proteins have selective effects on expression and signalling
- Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024
cardiomyocyte-specific Adhesion G Protein Coupled Receptor G1 (ADGRG1/GPR56) promotes pressure overload-induced heart failure GPCR Activation and Signaling Positive allosteric modulation of a GPCR ternary complex GPCR
- 📰 GPCR Weekly News, March 27 to April 4, 2023
Receptor autoantibodies: Associations with cardiac markers, histology, and function in human non-ischaemic heart failure.
- 📰 GPCR Weekly News, January 30 to February 5, 2023
Receptor autoantibodies: Associations with cardiac markers, histology, and function in human non-ischaemic heart failure.
- Hear the sounds: the role of G protein-coupled receptors in the cochlea
in the cochlea into electrical signals, which are transmitted by spiral ganglion neurons (SGNs) and heard disorders, and the treatment for hearing loss. In addition, hearing loss can be caused by mutations of certain GPCRs, such as Vlgr1, Gpr156, S1P2, and And A1, A2A, and CB2 activation by agonists has protective functions on noise- or drug-induced hearing loss, and hearing protection."
- TRPM3 in the eye and in the nervous system - from new findings to novel mechanisms
August 2022 "The calcium-permeable cation channel TRPM3 can be activated by heat and the endogenous steroid TRPM3's best understood function is its role as a peripheral noxious heat sensor in mice.
- 4GPCRnet, September 26-29, 2022. Leipzig, Germany
The event will take place in the heart of Leipzig, which offers a colorful mixture of culture and vivid
- Targeted Therapies to Reduce Side Effects in Modern Drug Development
In fact, it is often costly, frustrating, and tortuous—and more often than not it ends in failure.
- 4GPCRnet - International Symposium
The event will take place in the heart of Leipzig, which offers a colorful mixture of culture and vivid
- Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies
Propranolol, initially prescribed for high blood pressure, irregular heart rate, essential tremor, and
- The Bile Acid Membrane Receptor TGR5 in Cancer: Friend or Foe?
TGR5 is widely distributed in the brain, lung, heart, liver, spleen, pancreas, kidney, stomach, jejunum
- Rescue of Cell Surface Expression and Signaling of Mutant Follicle-Stimulating Hormone Receptors
Many cause receptor misfolding and failure to reach the cell surface.
- G protein-biased GPR3 signaling ameliorates amyloid pathology in a preclinical Alzheimer's disease..
pathways, are leading to the development of drugs with superior efficacy and reduced side effects in heart
- 📰 GPCR Weekly News, October 2 to 8, 2023
development of databases supporting medical research ‘Define your own success’: Duke leaders talk success, failure
- 📰 GPCR Weekly News, June 12 to 18, 2023
and Immunology The GPCR-Gαs-PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure
- Reflections on My PhD Journey: Lessons Learned
The Importance of Experimental Controls Experiments are at the heart of a PhD in the sciences, and one
- 📰 GPCR Weekly News, July 17 to July 23, 2023
GPCRs in Oncology and Immunology A GPCR checkpoint drives CD8+ T cell dysfunction and immunotherapy failure
- 📰 GPCR Weekly News, June 5 to 11, 2023
Immunology and Oncology The GPCR–Gαs–PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure